Back to Dashboard
PACB · Healthcare

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

USA Healthcare Filing: 2025-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
32
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. PACIFIC BIOSCIENCES OF CALIFORNIA, INC. is not currently in our model portfolio, but 6 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$447M
Industry
Medical Devices
Exchange
NasdaqGS
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solutions to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-read sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries…
6
Investors
2
New positions
3
Increasing
1
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Point72 (Steve Cohen)
Trust weight: 1.1×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of Point72's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
New position
% of portfolio
0.0%
Position change
NEW
0.0% of D.E. Shaw & Co's portfolio
ARK Invest (Cathie Wood)
Trust weight: 1.3×
Increased +20%
% of portfolio
0.5%
Position change
+20%
0.5% of ARK Invest's portfolio
Citadel Advisors
Trust weight: 1.0×
Increased +27%
% of portfolio
0.0%
Position change
+27%
0.0% of Citadel Advisors's portfolio
AQR Capital Management
Trust weight: 1.0×
Increased +69%
% of portfolio
0.0%
Position change
+69%
0.0% of AQR Capital Management's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Decreased −12%
% of portfolio
0.0%
Position change
−12%
0.0% of Millennium Management's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell PACIFIC BIOSCIENCES OF CALIFORNIA, INC. or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API